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P-selectin  expressed  on the surface of endothelium mediates 
leukocyte adhesion in vitro and rolling in vivo.  Several  in- 
ducers of cell-surface  P-selectin  expression on endothelial 
cells (EC) have previously been identified, all of which yield 
transient cell-surface  expression  of  P-selectin  lasting min- 
utes to a few hours. We  now show that a T-lymphocyte 
product, interleukin-3 (IL-3). stimulates the long-term ex- 
pression of P-selectin  on cultured human umbilical vein en- 
dothelial cells (HUVEC). IL-3 induced cell-surface  P-selectin 
expression in  two phases. An initial  peak at 10 minutes was 
followed by a prolonged upregulation beginning 16 hours 
after IL-3 addition and lasting at least 4 days.  The level of P- 
selectin  expression  induced by IL-3  added  for 48  hours was 
similar to that induced by treatment of  HUMC  for 10 min- 
utes with  thrombin, and  the effect of adding IL-3  for 48 hours 
followed  by  thrombin  for  10  minutes  was  additive. 
HE CELLULAR COMPONENTS of  inflammation are 
derived from the blood and migrate into tissues by  a 
complex process involving rolling, adhesion, and transmi- 
gration.' The selectins mediate rolling and are essential adhe- 
sion molecules for the development of inflammation.' There 
are  three  members in  the  selectin family,  two  of  which, 
E- and P-selectin, are expressed on human umbilical vein 
endothelial cells (HUVEC) after stimulation. The importance 
of P-selectin in mediating rolling and subsequent leukocyte 
recruitment during inflammation is evidenced by the lack of 
rolling in  mesenteric vessels and delayed extravasation of 
neutrophils into the peritoneal cavity in  P-selectin knock- 
out mice during experimentally induced inflammation.' 
E-selectin expression is upregulated after stimulation by 
cytokines such as interleukin (1L)-l, tumor necrosis factor 
a  (TNFa),"6 and, as has been shown more recently, IL-3,7.' 
with peak expression occumng between 4 and 6 hours after 
addition of stimulus. In contrast, cell surface expression of P- 
selectin can be rapidly induced by agents such as histamine, 
thrombin, and phorbol myristate acetate (PMA)?'" with  peak 
expression occurring at approximately 10 minutes after addi- 
tion of  stimulus. Upregulation of cell-surface E-selectin ex- 
pression is the result of  transcriptional activation of  the E- 
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Induction of  cell-surface  P-seiectin  expression by IL-3 was 
blocked by pretreatment of EC with a blocking monoclonal 
antibody against the IL-3  receptor  a-chain.  Lipopolysaccha- 
ride (LPS), tumor necrosis factor a (TNFa), and  a  mutant 
form of  IL-3  with decreased potency did  not  induce  cell- 
surface  P-selectin  expression  after 48 hours' incubation with 
HUVEC, suggesting  that  the  effect was specific to IL-3.  The 
increase in cell-surface  P-selectin  expression  occurring after 
16 hours of incubation with IL-3 was accompanied  by a simi- 
lar prolonged increase in the steady-state mRNA level that 
was not observed at 10 minutes after IL-3 addition. As  T- 
lymphocyte infiltration is a hallmark of chronic inflamma- 
tion, our  observations  suggest  that  the  secretion of IL-3  by T 
lymphocytes may  serve  to maintain the inflammatory state 
during chronic inflammation. 
0  1996 by  The  American  Society  of Hematology. 
selectin gene, whereas P-selectin is  stored  in  granules in 
endothelial cells (EC) called Weibel-Palade bodies. The ex- 
istence of  a preformed pool of  P-selectin, therefore, enables 
it to be rapidly translocated to the cell surface (within 5 to 
10 minutes) after stimulation, suggesting an important role 
for this molecule in acute inflammation. 
Other agonists such as oxygen radicals can induce a differ- 
ent time-course of P-selectin expression on HWEC, with a 
peak  at  about 2 to 4 hours after addition of  stimulus."  In 
mouse EC, TNFa has also been shown to induce both mRNA 
and cell-surface P-selectin expression with similar kinetics 
to that of  E-selectin induction." In mice injected with lipo- 
polysaccharide (LPS), P-selectin mRNA  levels were found 
to  be  induced with a peak at about 4 hours postinjection.13 
These studies demonstrate that the kinetics of  P-selectin ex- 
pression and whether cellular mRNA  levels are altered de- 
pends on the agonist used, which  may  reflect the physiologic 
role of P-selectin in  vivo. 
IL-3, a product of  mature T cells and mast cells14~"  after 
activation, is classically described as a hematopoietic growth 
factor. However, it has recently been recognized as an endo- 
thelial cell acti~ator~.~  and may play a role in inflammation. 
HUVEC express high  affinity  IL-3 receptors  the ex- 
pression of which  is increased after stimulation with TNFa, 
IL-lp, or  LPS.'  IL-3  binding to  its receptor on  HUVEC 
resulted in enhanced IL-8 production by HUVEC, increased 
E-selectin  expression,  and  neutrophil  transmigration  in 
vitro.','  Although the factors giving rise to acute expression 
of selectins is well understood, the molecular mechanism of 
prolonged or chronic selectin expression is as yet  not known. 
As T cells are typically involved in chronic inflammation, 
we hypothesize that IL-3 may be a mediator of  chronic in- 
flammation. 
In this report, we  show  that IL-3 increased the expression 
of  cell-surface P-selectin on HUVEC, with  peak expression 
occurring at  10 minutes and a prolonged plateau of upregu- 
lated expression from 16 hours to at least 4 days after the 
addition of IL-3. The second phase of  cell-surface P-selectin 
expression, but  not  the  initial  peak, was accompanied by  an 
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increase in the steady-state P-selectin mRNA  level.  These 
observations suggest that IL-3-mediated  upregulation of  P-. 
selectin may participate in  both acute and chronic inflamma- 
tion. 
MATERIALS  AND  METHODS 
Culture  of HUVEC.  HUVEC  were  extracted  by  collagenase 
treatment according to a modified version of  that of Wall et al.16 
Cells  were  grown in  25-cm2, gelatin-coated tissue  culture flasks 
(Costar, Cambridge, MA) in endotoxin-free M199 medium (Cyto- 
systems, Sydney, Australia), 20% fetal calf serum (FCS) (PA Biolog- 
ical, Sydney, Australia), 20 mm01  L"  HEPES with sodium pyruvate, 
nonessential amino acids, and Fungizone at 37°C in a 5% CO2 atmo- 
sphere. Cells were used 2 to 5 days after establishment of culture 
by harvesting with trypsin (0.05%)-EDTA (0.02%) (Multicel, Trace 
Biosystems, Australia) for replating. After replating, endothelial cell 
growth supplement (Collaborative Research, Bedford, MA) at 25 
mg  mI"  and  heparin were included in the culture medium. All 
reagents used in the growth and passaging of HUVEC were made 
up under endotoxin-free conditions and contained between 10  and 
100 pg mI"  endotoxin using the limulus amoebocyte assay. 
Flow  cytometry  to  detect  cell-surjme  P-selectin  expression. 
After IL-3 stimulation at various times after plating, HUVEC were 
removed  at  the  end  of  the  experiment  with  trypsin-EDTA and 
washed twice with fresh medium. Cells were then incubated on ice 
with a rabbit polyclonal antibody (Ab) against human platelet P- 
selectin17 at 10 pg mI-l in the presence of  0.02% (wt/vol) azide, 
5% newborn calf serum for 30 minutes. The polyclonal P-selectin 
Ab used bound specifically to P-selectin and did not crossreact with 
E-selectin expressed on the surface of Chinese hamster ovary (CHO) 
cells transfected with the E-selectin cDNA (data not shown). Cells 
were washed twice at 4°C before the addition of fluorescein isothio- 
cyanate  (HTC)-conjugated  sheep  anti-rabbit IgG Fab2 secondary 
Ab (Menus, Victoria, Australia) at a 1:80 dilution. The cells were 
incubated on ice for 30 minutes, washed once, and then fixed  in  1% 
formaldehyde, 2%  (wthol) glucose and 0.02% (wt/vol) sodium azide 
in phosphate-buffered saline (PBS). Flow cytometry was performed 
using an EPICS Profile 11  (Coulter, Hialeah, FL);  10,OOO cells per 
group were analyzed. 
HWEC were  also stained with several anti-P-selectin  mono- 
clonal  antibodies  (MoAbs): AK6"  (commercially available from 
Cymbus Bioscience, Hampshire, UK), CRC 81 (gift from Dr A. 
Lazirov), and P5E8 (made by immunizing mice with purified human 
platelets). P5E8 was shown to be  specific for P-selectin by positive 
staining on P-selectin-transfected  CH0 cells and negative staining 
on nontransfected, L-selectin-transfected,  or E-selectin-transfected 
CH0 cells and  the  surface of  resting EC  (C.M.B.  and  Y.K.-G., 
unpublished observations, October  1993). Hybridoma supernatant 
was  used  for staining. MoAb binding was detected using an FITC- 
conjugated sheep anti-mouse IgG secondary Ab. The anti-L-selectin 
MoAb DREG 56 was obtained from American Type Culture Collec- 
tion (ATCC; Rockville, MD). 
RNase protection  assay  to detect  P-selectin  mRNA.  A 422-bp 
fragment of P-selectin cDNA (a gift from Dr G. Larsen, Genetics 
Institute, Boston, MA) from nucleotides (nt) 2097 to  2519"  was 
subcloned into the vector pGEM-l.  The plasmid was linearized and 
transcribed using l7  RNA polymerase in the presence of  "P-uridine 
triphosphate (UTP) as described"  to  generate a full-length cRNA 
probe  of  470  bases  that  would protect a  fragment of  422  bases 
when hybridized to the transmembrane domain containing mRNA. 
A  human  glyceraldehyde-3-phosphate  dehydrogenase  (GAPDH) 
cRNA  probe  containing  103  complementary  nt  to  the  human 
GAPDH mRNA was used as an internal standard. The specific radio- 
activity of the GAPDH probe used was 40 times lower than that of4 
the P-selectin probe. 
Total RNA from HUVEC was isolated as previously described;" 
10 pg of HUVEC total RNA was hybridized to both the P-selectin 
and GAPDH cRNA probes, followed by digestion with 40  pg mL" 
RNase A, essentially as described.20  The resulting protected frag- 
ments were resolved by electrophoresis on 6% polyacrylamide gels 
containing 8 mol L"  urea. The molecular weight markers used were 
32P-labeled  pUC  19 DNA  digested with  Hpu  11.  The amount of 
radioactivity in each band was visualized using a phosphorimager 
and quantified using ImageQuant software (Molecular Dynamics, 
Sunnyvale, CA).  The level of  P-selectin mRNA  expression was 
calculated as a ratio of GAPDH mRNA expression. 
IL-3,  mutant IL-3,  thrombin, andpolymyxin B suvate.  Recombi- 
nant human IL-3 was from Genetics Institute and contained less than 
100 pg mI-l LPS as judged by the limulus amoebocyte assay. The 
recombinant mutant IL-3, m47,  was  expressed and purified from 
Escherichia  coli  as previously described?'  Human thrombin and 
polymyxin B sulfate were obtained from Sigma Chemical CO (St 
Louis, MO), and LPS  (E coli  055:b5 Westphal) was from Difco 
Laboratories (Detroit, MI). 
RESULTS 
Time course of  IL-3 induction of  cell-su~ace  P-selectin 
expression  on  HUVEC.  We  have  previously  shown  that 
unstimulated  HUVEC expressed substantial amounts of  IL- 
3R a-  and P-chain mRNAs.  We  show here by  flow cytome- 
try using  a  rabbit anti-human  P-selectin  polyclonal Ab that 
addition of IL-3 to first-passage  HUVEC resulted in a  time- 
dependent increase in cell-surface expression of  P-selectin 
(Fig  1). The time course of  P-selectin expression showed 
two distinct phases of  induction by L-3: an  early  or acute 
phase  that  occurred  very  rapidly  and  peaked  within  10  min- 
utes  of  IL-3  addition (Fig  1, inset) and a  late phase that 
began at about  16 hours after IL-3 addition and lasted at 
least 4  days.  A  typical flow  cytometry  profile  showing the 
increase in P-selectin expression after 48 hours of incubation 
with IL-3 is shown  in  Fig  2A.  A  similar increase in P-selectin 
expression was also observed using  three  different MoAbs 
against P-selectin (Table 1).  A  typical flow  cytometry  profile 
using  MoAb  AK6,  which  is very  similar to that  obtained 
using the polyclonal Ab, is shown  in Fig 2B. 
The mean (? SEM) fold induction above basal  was  1.52 
+-  0.07 (n = 15) at 10 minutes and  1.91  2 0.11 (n = 12) at 
48 hours,  and  both  increases were  significantly  above that 
of basal P-selectin expression. The same pattern of induction 
was also observed using HUVEC  plated  in  the  absence of 
heparin and growth factor (data  not  shown). The increases 
in cell-surface P-selectin expression induced by IL-3 at  10 
minutes (Figs 1 and 4) and 48 hours (Fig 1) were  reproduc- 
ible and comparable in extent to the  upregulation  observed 
10 minutes after the addition of thrombin (Fig 4), PMA, or 
histamine as  inducer^.^ 
We have also investigated the effect of  IL-3  stimulation 
for  48  hours in  primary  HUVEC.  In  these experiments, HU- 
VEC  were  plated  directly onto 24-well trays immediately 
after explant and  grown  until  a  confluent  monolayer  was 
established (usually between  3  and  5 days). Cells were then 
either left unstimulated, stimulated with IL-3 for 48 hours, 
or stimulated with  thrombin  for  10 minutes, followed by 
fixation in  1% paraformaldehyde for  10  minutes  at  room 
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Fig 1.  Time  course  of L-3-induced cell-surface  P-selectin  expres- 
sion on HUVEC detected  by  flow cytometry. HUVEC on first passage 
were plated onto gelatin-coated 24-well tissue culture dishes at 2 x 
lo6  cells  per  well,  as described in Materials  and  Methods.  Cells were 
stimulated with IL-3 at 30 ng mL"  for various lengths of time and 
harvested at the end  of the experiment.  (Inset)  Mean  fold induction 
of  P-selectin  expression  in  the  first 4 hours after IL-3 addition. Basal 
expression  was  determined using  cells  that had not received 11-3 
for the duration of the experiment. Basal mean  immunofluorsrrcence 
(MFI) obtained  with different lines  of HUVEC varied  between  0.8 and 
4.0 after background subtraction (using rabbit non-immune  serum 
as negative control). Fold induction for each time point for each line 
of HUVEC  used  was  calculated  as (MFI - background)/(MFl,,-,  - 
background),  and the mean fold induction at each time point was 
obtained using at least four lines of HUVEC,  except at 98 hours  after 
IL-3  addition,  where n = 2  and  error  bar  represents  standard  devia- 
tion. *P c  .01 comparing  MFI at 48 hours of  IL-3 (n = 121 and tP  < 
.05 comparing Mfl  at 10 minutes of  11-3  (n = 15) with basal  MFI (n 
= 24) using an  unpaired t test. 
temperature.  After  fixation,  adherent  cells were incubated 
with  primary  Ab  and  detected using  '251-protein  A.  Using 
this approach to detect cell-surface P-selectin expression, we 
observed a 3.3- 2 0.5-fold  (mean  -C  SEM; n = 3) induction 
with  thrombin  (10 minutes)  and  1.9- 2 0.4-fold  (mean  -C 
SEM; n = 3) induction  with  IL-3 (48 hours), which  is not 
significantly different from  that  induced  by  thrombin (P = 
.l).  We, therefore, concluded  from  these  data that (1) throm- 
bin  and  IL-3 stimulate cell-surface P-selectin expression to 
a similar extent in both  primary  and  first-passage  HUVEC, 
(2) a  similar fold induction was  elicited by  each agonist 
used,  whether  the cells were stained unfixed  in  suspension 
on ice in the presence of azide or stained  while  still  adherent 
after  fixation,  and  (3) trypsinization of the cells before stain- 
ing did not appear to influence the level of induction of cell- 
surface P-selectin by  L-3. For all subsequent experiments 
described, cell-surface P-selectin expression was detected by 
flow cytometry of  cells stained  in  suspension. 
Specijicity  of P-selectin  upregulation  induced  by IL-3 at 
48 hours.  The induction of  P-selectin  expression  at 10 min- 
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Fig 2.  Flow  cytometry profiles  of  cell-surface  P-selectin  expression 
induced by 11-3 detected using (A) a polyclonal anti-P-selectin  Ab 
and (B) the MoAb AK6.  HUVEC  were either not Mmuhted (nil) or 
stimulated with 11-3 for the times indicated in the figure,  after which 
they were  processed  for flow cytometry as described in Materials 
and  Methods.  The  negative  control MoAb  used in panel B was the 
anti-L-selectin MoAb,  DREG  56. 
Utes  and  48 hours  after  IL-3  addition  was  inhibited  signifi- 
cantly by  a blocking anti-IL-3R  a-chain MoAb, 7.G3 (Fig 
3), whereas an  isotype-matched irrelevant Ab  had  no sig- 
nificant effect. To further establish that  the  upregulation  of 
cell-surface P-selectin  at  48 hours  was  specific  to IL-3, we 
also examined the effect of incubating HUVEC for 48 hours 
with TNFa; a mutant  IL-3,  m47,  which  had  an  approximately 
1,000-fold lower  potency  than  wild-type  IL-3 prepared in 
Table 1.  Cell-Surface  P-Selectin  Expression  Detected 
by a Panel  of  Anti-P-Selectin  MoAbs 
Stimulation  AK6  CRC  81  P5EB 
No  IL-3  0.434  0.521  0.270 
10 minutes of IL-3  0.731  0.910  0.503 
24 hours of IL-3  1.026  1.146  0.772 
Data represent MFI - background MFI;  background MFI was ob- 
tained using a negative control MoAb (anti-L-selectin,  DREG 56). 
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Fig 3.  The  induction  of  cell-surface  P-selectin  expression  is  spe- 
cific  for IL-3. The  MoAb 7G3 (anti-IL-3R  cr-chain;  lgG2a)  and the iso- 
typematched control 68-2A1 [anti-E-selectin)  were  added  at  100 pg 
mL",  45 minutes  before the addition of  11-3.  Flow qtometry using 
the polyclonal  anti-P-selectin  Ab  to detect cell-surface  P-selectin  ex- 
pression  was  as  described  in  Materials  and  Methods.  *Percent  con- 
trol was  calculated  as MFI + Ab/MFI -  Ab  for  no 11-3 added, IL-3 for 
10  minutes or  I13  for  48 hours. *P  < .05 for  10 minutes of  11-3 
treatment,  and  P < .01 for  48 hours  of  IL-3 treatment  comparing 
MoAb 763 with the isotype-matched  control  In = 3). The  average 
MFI obtained in the absence  of  any Ab  for  no 11-3 added, 10 minutes 
after IL-3, and 48 hours  after 11-3 was 1.794.3.157, and 3.625, respec- 
tively (n = 31. 
the same manne9';  or LPS. No increase in cell-surface P- 
selectin expression was observed using either the mutant IL- 
3, TNFa, or LPS (Table 2). Thrombin alone added for 24 
hours  or  48  hours  did  not  induce cell  surface P-selectin 
expression (data not shown). The inclusion of  10 or 100 pg 
rd" polymyxin B with IL-3 also did not significantly alter 
the increase in P-selectin expression induced by IL-3 (Table 
2). Polymyxin B at 10 pg rd" inhibited the induction of 
E-selectin expression by  LPS (1 pg rd")  by 70%, and at 
100 pg mI",  E-selectin expression induced by  LPS  was 
completely inhibited (data not shown). 
Additive effect of thrombin and IL-3  in upregulating cell- 
sugace P-selectin  expression.  The time course of  throm- 
bin-induced cell-surface P-selectin expression on HUVEC 
pretreated with IL-3 was parallel to that observed in HWEC 
Table 2. Specificity of Cell-Surface  P-Selectin  Expression 
Induced  by  IL-3 
Treatment  Mean ? SD (n = 2) 
None 
None + polymyxin B 
TNFa (1 U mL") 
IL-3 (30 ng mL") 
IL-3 + polymyxin B 
Mutant IL-3 + polymyxin B 
LPS (1  pg mL") 
LPS + polymyxin B 
1  .oo 
1  .oo 
1.01 ? 0.30 
1.85 ? 0.00 
1.76 t  0.26 
1.05 t  0.07 
1.25 ? 0.25 
1.14 ? 0.01 
Data  represent fold induction  over  unstimulated  P-selectin  expres- 
sion, or, in  the  cases  where polymyxin  B was  added,  the fold induction 
was  relative  to  none  + polymyxin B. Polymyxin B was  used at 10 pg 
mL"  in  experiment 1 and at 100 pg mL"  in  experiment 2. Mutant IL- 
3 was  used  at 300 ng  mL"  in  experiment 1 and 30 ng  mL"  in  experi- 
ment 2.  IL-3,  LPS,  TNFa, and polymyxin B were added  for  48 hours. 
* 
48  h IL-3 
a NO  IL-3 
0123456 
Time  after  thrombin  addition  (h) 
Fig 4.  Time course  of  P-selectin  expression  on  HUVEC  induced 
by thrombin with or without IL-3 pretreatment.  HUVEC  plating, IL-3 
stimulation,  and  flow cytometry were  performed as described in Fig 
l.  Thrombin at 1 U mL"  was added to resting  HUVEC  or to HUMC 
stimulated with 11-3 for 48 hours  and left for  various  times  as  indi- 
cated  before  cells  were  harvested  for flow  cytometry. *P  < .01 com- 
pared with MFI  for  thrombin,  10 minutes,  and  P  <  .05 compared with 
MFI  for IL-3, 48  hours,  using  a paired t test in = 2). 
that had  not  been previously exposed to IL-3; ie, P-selectin 
expression peaked at 10 minutes after thrombin addition and 
declined after 30 minutes (Fig 4). The absolute level of P- 
selectin expression, however, was higher in cells pretreated 
with IL-3 at all time points after thrombin addition. At the 
peak  of  thrombin stimulation (10 minutes), the level of  P- 
selectin expression induced by  thrombin after 48 hours of 
IL-3 pretreatment was  significantly  higher than that obtained 
with either stimulus alone. 
Time course of P-selectin mRNA induction by IL-3. To 
determine whether IL-3 induced solely the degranulation of 
Weibel-Palade bodies that  led to the increase in cell-surface 
expression of  P-selectin, we also examined the effect of IL- 
3 on the steady-state level of P-selectin mRNA  in  HUVEC. 
We found that the P-selectin mRNA was also increased by 
IL-3 (Fig 5), but unlike the upregulation of  cell-surface P- 
selectin expression, IL-3 induced an increase in mRNA  only 
after 16 hours of IL-3 stimulation (Fig 5A and B). Like the 
increase in cell-surface expression observed at 48 hours, the 
mean (kSEM) fold induction in P-selectin mRNA expres- 
sion above basal was 1.92 5 0.22 (P < .05; n = 4) and was 
also prolonged, lasting at least 96 hours (Fig 5A). The RNase 
protection probe used also detected the transmembrane-lack- 
ing forms of P-selectin mRNA,  with expected bands of 229 
and 73 bases. However, the protected fragment of 73 bases 
did not migrate as a discrete band and, hence, appeared less 
intense than expected. This is probably due to the possibility 
of stem-loop formation in the vector sequences at the 3' end 
of  the cRNA probe that is resistant to complete digestion, 
resulting in fragments of varying lengths rather than a frag- 
ment of discrete length. The data showed that the mRNA 
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for the transmembrane-lacking form also responded in the 
same way to IL-3 as the transmembrane-containing forms 
(Fig 5B). 
DISCUSSION 
In  this report, we have shown that IL-3 upregulated the 
expression of P-selectin, a key determinant in leukocyte roll- 
ing and adherence, on the surface of  HUVEC, thus further 
substantiating its role as an  immune cytokine. Importantly, 
IL-3 induced not  only  an  acute phase of  P-selectin expres- 
sion,  which  had  previously  been  documented with  other 
stimuli, but it also induced a prolonged late-phase P-selectin 
expression that is novel. The late-phase P-selectin expression 
lasted at least 4 days  after the  addition of  IL-3  and  was 
concomitant with  an  increase in the steady-state level of  P- 
selectin mRNA over the same period.  Upregulation  of  P- 
selectin mRNA  by  IL-3  is  another novel  observation, as 
previously known inducers of P-selectin expression on  HU- 
VEC did not alter steady-state P-selectin mRNA levels. We 
speculate that upregulation of steady-state P-selectin  mRNA 
level may be required to maintain the prolonged increase in 
cell-surface expression. 
1.8 - 
The prolonged late-phase induction of P-selectin expres- 
sion by  IL-3 appeared to be  specific to  IL-3  based  on  the 
following  criteria.  A  recombinant  mutant  form  of  L3 
1.6 -  (m47), TNFa (a known activator of endothelial cells), and 
1.4 - 
LPSz3  and thrombin (both previously shown to be acute in- 
ducers of cell-surface P-selectin expression) did  not  induce 
P-selectin expression when added to HUVEC for 48 hours. 
1.2 -  Moreover, a MoAb to the IL3R  a-chain was able to partially 
1.0 - 
block the effect of IL-3.  Although  all  precautions were  taken 
to ensure that endotoxin levels in the experiments were  negli- 
0.8 
gible and the IL-3 preparation used contained less than  100 
I'I'I'I'I'I'  pg mL"  endotoxin, there remained the possibility  that trace 
0  20  40  60  80  100  120  amounts of endotoxin may be sufficient to either elicit the 
response observed or to prime the stimulation by IL-3.  How- 
of  the  stimulation by  IL-3 did  not  significantly  alter the 
2.2 
2.0 -  A 
0.8 
012 
Time (hours)  ever, the addition of polymyxin B to the cells for the duration 
147-  I 
111 
110' 
induction of  P-selectin expression by  IL-3, suggesting that 
the effect  is  not  likely to  be  mediated by  endotoxin  and 
that the induction does not  require priming by  endotoxin. 
Although IL-3 increases E-selectin expression at 4 hours, no 
chronic upregulation of E-selectin or vascular cell adhesion 
molecule  1 (VCAM-l) has been observed (J.R.G.,  unpub- 
lished observations, September 1993). 
It has previously been established that the rapid  upregula- 
tion of  cell-surface P-selectin expression on  HUVEC  after 
stimulation by  agents such as PMA  or histamine is due to  -  229b l"(-) 
Fig 5.  (A) Time course of IL-3-induced,  steady-state P-selectin 
mRNA expreuion  on  HUMC.  HUVEC were  plated  and  stimulated 
with IL-3  as  described in Fig 1.  P-selectin mRNA levels were deter- 
mined using  an  RNase  protection assay  and  normalized  to the 
calculated  as  P-se1ectin:GAPDH  at time  t/basal  P-se1ectin:GAPDH. 
Each point represents the mean of two experiments. (Inset) Mean 
fold  induction  of  P-selectin mRNA in the  first  2 hours after IL-3 addi- 
tion. (B) RNase protection gel showing  protected  fragments from 
transmembrane  domain-containing  forms  of P-selectin (P sell,  the 
transmembrane-lacking  form  [229b  TM(-)  and  73b  TMt-11,  and 
GAPDH bands without  or  with  IL-3 added for 48 hours. The data 
are from one representative experiment  of four, and the  ratio  of P- 
se1ectin:GAPDH  (P  sel:GAPDH)  mRNA  as  quantified  using  a phos- 
phorimager  is  shown  below  each  lane. The molecular weight (MW) 
markers used were =P-labeled pUC19IHpa II DNA,  and  the sizes of 
the bands are indicated  on  the  left. Both  the P-selectin and GAPDH 
-  GAPDH  GAPDH  mRNA  after quantitation. The fold  induction  at  time  t was 
J  73b W(-) 
@  p se la^^^^  probes  when  hybridized  to  tRNA and digested under identical condi- 
tions gave blank lanes (not shown). 
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translocation to the plasma membrane and subsequent de- 
granulation of Weibel-Palade bodies, the storage granules of 
P-selectin in HUVEC."  It, therefore, follows that the rapid 
induction of cell-surface P-selectin after the addition of  IL- 
3 was  likely to be  due  also to  degranulation of  Weibel- 
Palade bodies. 
An  intriguing question arising from our observation that 
IL-3 also induced a later prolonged cell-surface upregulation 
of  P-selectin expression is  the  mechanism by  which this 
occurs. The concomitant increase in P-selectin mRNA in- 
duced by IL-3 suggests that de novo protein synthesis may 
be necessary. Consequently, an excess of P-selectin protein 
may  be produced compared with basal levels, which  may 
have two possible fates. The excess protein may be packaged 
into Weibel-Palade bodies and translocated to the cell sur- 
face as normal, or the excess protein synthesized may satu- 
rate the  storage pathway and  be exported directly to  the 
plasma membrane. The observation that thrombin added for 
10 minutes after stimulating HUVEC for 48 hours with IL- 
3  resulted  in  a  further  increase in  cell-surface P-selectin 
expression suggests that different signaling pathways for 48- 
hour IL-3 and thrombin induction may exist. The signaling 
pathway induced by 48  hours of IL-3 may result in degranu- 
lation of a different subset of Weibel-Palade bodies from that 
induced by  thrombin or  may  lead  to a completely different 
pathway of  export. 
The prolonged increase in P-selectin expression also poses 
the question of  the half-life (tIl2)  of  P-selectin on the cell 
surface after prolonged IL-3 treatment. P-selectin expression 
induced by  agents such as thrombin and histamine is nor- 
mally rapidly reabsorbed into the cell. However, it is not 
known whether P-selectin on the cell-surface after prolonged 
IL-3 treatment is turned over at the same rate. Prolonged cell- 
surface P-selectin expression may, therefore, be the result of 
continuous output of P-selectin to the cell surface or, it may 
be the result of an increase in the tllZ  of the molecule on the 
cell-surface. The similarly rapid loss of P-selectin from the 
cell surface after thrombin stimulation in HUVEC that had 
been exposed to IL-3 for 48 hours compared with resting 
HUVEC suggests that there is not  an overall increase in the 
tIl2  of  cell-surface P-selectin; otherwise, the increase in P- 
selectin expression induced by thrombin plus IL-3 would  be 
less transient. However, our currently available data cannot 
rule out the possibility that IL-3 induces a different isoform 
with a longer t1,2. 
So far, upregulation of  P- or E-selectin on  the surface 
of endothelium by known proinflammatory molecules only 
results in transient expression of  these two selectins. This 
does not  correlate with the long term increase in  P-  or E- 
selectin expression observed in vivo in certain chronic in- 
flammatory diseases such as rheumatoid arthritis,''  Graves 
disease,26  and allergic rhinitis:'  where increased cell-surface 
P-selectin expression have been observed. Our results repre- 
sent the first  in vitro observation of prolonged or chronic P- 
selectin expression on HUVEC. Together with the observa- 
tions that IL-3 is a product of activated T lymphocytes and 
that  progression from  acute to  chronic inflammation also 
includes T lymphocyte infiltration before subsequent mono- 
cyte infiltration, our observations may have important impli- 
cations for the establishment and  maintenance of  chronic 
inflammatoIy diseases. 
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